The epidemiology of psychiatric disorders in Africa: a scoping review.

The Lancet. Psychiatry
M Claire GreeneMyrna M Weissman

Abstract

This scoping review of population-based epidemiological studies was done to provide background information on the prevalences and distribution of psychiatric disorders in Africa for calls to broaden diversity in psychiatric genetic studies. We searched PubMed, EMBASE, and Web of Science to retrieve relevant literature in English, French, and Portuguese from Jan 1, 1984, to Aug 18, 2020. In 36 studies from 12 African countries, the lifetime prevalence ranged from 3·3% to 9·8% for mood disorders, from 5·7% to 15·8% for anxiety disorders, from 3·7% to 13·3% for substance use disorders, and from 1·0% to 4·4% for psychotic disorders. Although the prevalence of mood and anxiety disorders appears to be lower than that observed in research outside the continent, we identified similar distributions by gender, although not by age or urbanicity. This review reveals gaps in epidemiological research on psychiatric disorders and opportunities to leverage existing epidemiological and genetic research within Africa to advance our understanding of psychiatric disorders. Studies that are methodologically comparable but diverse in geographical context are needed to advance psychiatric epidemiology and provide a foundation for understanding enviro...Continue Reading

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Jul 18, 1992·Lancet·G LewisP Allebeck
Dec 1, 1987·Journal of Abnormal Child Psychology·T M AchenbachC T Howell
Jan 1, 1974·Behavioral Science·L R DerogatisL Covi
Oct 1, 1984·Archives of General Psychiatry·L N RobinsD A Regier
Oct 1, 1984·Archives of General Psychiatry·D X Freedman
Jul 1, 1997·Journal of Child Psychology and Psychiatry, and Allied Disciplines·R Goodman
Sep 2, 1999·Acta Psychiatrica Scandinavica. Supplementum·D Kebede, A Alem
Sep 2, 1999·Acta Psychiatrica Scandinavica. Supplementum·D Kebede, A Alem
Sep 2, 1999·Acta Psychiatrica Scandinavica. Supplementum·D Kebede, A Alem
Jun 20, 2000·Schizophrenia Research·W W EatonM Frydenberg
Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
Oct 3, 2002·The Journal of Nervous and Mental Disease·Paul BoltonLincoln Ndogoni
Oct 24, 2002·Social Psychiatry and Psychiatric Epidemiology·Paul Bolton, Alice M Tang
Jul 2, 2003·Nature Medicine·Anthony S Fauci
Nov 14, 2003·Social Psychiatry and Psychiatric Epidemiology·D KebedeG Kullgren
Apr 20, 2004·Journal of Affective Disorders·Abebaw FekaduMichael J Owen
Jun 19, 2004·Social Psychiatry and Psychiatric Epidemiology·Paul BoltonLincoln Ndogoni
Apr 16, 2005·Journal of Studies on Alcohol·Charles D H ParryRia Laubscher
May 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Oye GurejeVictor A Makanjuola
May 24, 2006·Archives of Internal Medicine·Robert L SpitzerBernd Löwe
Jul 28, 2007·Acta Psychiatrica Scandinavica·W W EatonY Ding
Feb 5, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Dan J SteinDavid R Williams
Nov 6, 2008·JAMA : the Journal of the American Medical Association·Charles P O'Brien
Apr 22, 2009·Epidemiologia e psichiatria sociale·Ronald C KesslerPhilip S Wang
Jun 18, 2009·Current Opinion in HIV and AIDS·Peter H Kilmarx
Oct 9, 2009·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Renato D Alarcón
Jul 4, 2012·International Journal of Environmental Research and Public Health·Rachel JenkinsDavid Kiima
Jan 23, 2013·Global Health Action·Karl Peltzer, Nancy Phaswana-Mafuya

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.